Eliver Ghosn

Dec 2, 2024 | nature.com | Caterina E. Faliti |M. Williams |Natalie Haddad |Rustom Antia |John Lindner |Eliver Ghosn | +3 more

Correction to: Nature Immunology https://doi.org/10.1038/s41590-024-02010-9, published online 12 November 2024. In the version of the article initially published, in Fig. 4c, d, h and i, the colors of the keys did not match those in the bar charts. In Figs. 4h and 5g, the total cells layers were missing and in Fig. 2f and g the GMT values were not in red. These errors have now been corrected in the HTML and PDF versions of the article.

Nov 12, 2024 | nature.com | Caterina E. Faliti |M. Williams |Natalie Haddad |Rustom Antia |John Lindner |Eliver Ghosn | +3 more

AbstractSevere acute respiratory syndrome coronavirus 2 mRNA vaccination has reduced effectiveness in certain immunocompromised individuals. However, the cellular mechanisms underlying these defects, as well as the contribution of disease-induced cellular abnormalities, remain largely unexplored.

Jun 16, 2023 | frontiersin.org | Eliver Ghosn |Christopher M. Tipton |Matthew Woodruff

IntroductionRheumatoid arthritis (RA) is the commonest autoimmune mediated inflammatory arthritis, affecting 1% of the world’s population. As well as chronic, severe pain and early joint destruction, patients experience marked fatigue, accelerated cardiovascular disease and premature death (1, 2). Despite the heterogenous clinical presentation, the importance of pathogenic B cells has been established and further reinforced by the success of B cell depleting therapies (BCDT) (3, 4).